About 1,200 compassionate use requests are submitted to FDA annually, but how many never reached FDA because they were denied by a drug company? What other barriers to obtaining an investigational drug are there? To develop effective compassionate use policies, it is necessary to understand the unmet need. We want to hear about your experiences with compassionate use applications, whether for a cancer patient or for another indication. Thank you.